← Back to Patent Explorer
US4668513A Expired / Lapsed US ⏱️ 0.0 years remaining

Method for combating snoring

Assignee: Individual
•
Filing: 1985-08-05
•
Granted: 1987-05-26
•
Expires: 2005-08-05
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A method for overcoming snoring is disclosed. A composition is used containing a surface active substance, a preserving agent and/or a substance acting bactericidally or fungicidally on the mucous membranes and optionally a substance for softening the mucous membranes in physiological common salt solution as well as optionally further additives which are compatible with the mucous membranes.

Inventors

  • 👤 Dietrich Reichert

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-07 19:24
CPC Classifications
A; A61; A61K; A61K9/00; A61K9/0012; A61K9/0043; A61K31/00; A61K31/13; A61K31/14; A61P; A61P43/00

Claims Analysis

Total Claims: 15
Claim 1
Independent Claim 79 words
A method of combating snoring, in normal healthy humans which comprises administering to a snoring victim's nasopharyngeal mucous membranes, shortly prior to sleep a composition containing (a) 0.05 to 2% by weight of a surface active substance compatible with the mucous membranes and (b) 0.01 to 4% by weight of a pharmaceutically acceptable agent selected from the group consisting of a preserving agent and substances acting bactericidally or fungicidally on the mucous membranes, in a physiological common salt solution.
Claim 2
Independent Claim 79 words
A method of combating snoring, in normal healthy humans which comprises administering to a snoring victim's nasopharyngeal mucous membranes, shortly prior to sleep a composition containing (a) 0.05 to 2% by weight of a surface active substance compatible with the mucous membranes and (b) 0.01 to 4% by weight of a pharmaceutically acceptable agent selected from the group consisting of a preserving agent and substances acting bactericidally or fungicidally on the mucous membranes, in a physiological common salt solution.
Claim 3
Dependent Claim 24 words
The method according to claim 1 wherein the surface active agent is selected from the group consisting of anionic and cationic surface active agents.
Claim 4
Dependent Claim 28 words
The method according to claim 2 wherein the anionic and cationic surface active agent is selected from the group consisting of fatty alcohol sulfates, sulfosuccinates and benzalkonium halides.
Claim 5
Dependent Claim 37 words
The method according to claim 3 wherein the preserving agent is a substance selected from the group consisting of ethanol, esters of a p-hydroxybenzoic acid, 2-penoxy-ethanol, benzoic acid and its salts, and sorbic acid and its esters.
Claim 6
Dependent Claim 25 words
The method according to claim 4 wherein the softening compound is at least one substance selected from the group consisting of glycerol, sorbitol and panthenol.
Claim 7
Dependent Claim 29 words
The method according to claim 5 wherein the composition contains additionally at least one substance selected from the group consisting of vitamin A, vitamin E, hydrolases, lipaes and proteases.
Claim 8
Dependent Claim 25 words
The method according to claim 1, wherein the composition further contains 0.1 to 1% by weight of a softening compound for softening the mucous membranes.
Claim 9
Dependent Claim 25 words
The method according to claim 7 wherein the softening compound is at least one substance selected from the group consisting of glycerol, sorbitol and panthenol.
Claim 10
Dependent Claim 36 words
The method according to claim 1 wherein the preserving agent is a substance selected from the group consisting of ethanol, esters of p-hydroxybenzoic acid, 2-phenoxy-ethanol, benzoic acid and its salts, and sorbic acid and its esters.
Claim 11
Dependent Claim 34 words
The method according to claim 1 wherein as substance (a) and agent (b) one compound is selected in an amount of 0.01 to 4.0% by weight which exhibits both surface activity and preservative effect.
Claim 12
Dependent Claim 20 words
The method according to claim 10 wherein the compound is contained in an amount of 0.05 to 2% by weight.
Claim 13
Dependent Claim 15 words
The method according to claim 11, wherein the composition contains benzalkonium chloride as said compound.
Claim 14
Dependent Claim 14 words
The method according to claim 1 wherein the composition contains chlorobutanol as said substance.
Claim 15
Dependent Claim 29 words
The method according to claim 1 wherein the composition contains additionally at least one substance selected from the group consisting of vitamin A, vitamin E, hydrolases, lipases and proteases.

References Cited (Backward Citations)

US2989437A Cited
FR2379508A1 Cited
DE2805248A1 Cited
GB1599159A Cited
US4259323A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1990-05-25 1990-11-24 1991-05-26 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1994-05-25 1994-11-24 1995-05-26 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1998-05-25 1998-11-24 1999-05-26 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag